Proactive Research analyst Robin Davison joins Proactive's Katie to talk about MCG Pharmaceuticals' work with cannabinoids to combat brain cancer cells.
The company has reported some new data from preclinical laboratory studies done by its research collaborator, Slovenia's National Institute of Biology.
The data highlights the possible use of cannabinoids in the treatment of glioblastoma multi-formed (GBM), the aggressive, and most common, brain cancer.